Stock 6976 ACEPODIA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Acepodia, Inc.

Equities

6976

KYG0073G1091

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 10/06/2024 BST 		5-day change 1st Jan Change
27.45 TWD +0.55% Intraday chart for Acepodia, Inc. -1.08% -19.62%
05-08 Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma CI
02-06 US FDA OKs Acepodia's Investigational New Drug Application for Cancer Treatment MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
CI
US FDA OKs Acepodia's Investigational New Drug Application for Cancer Treatment
MT
Acepodia Biotech, Inc. Announces Clearance of Investigational New Drug Application by U.S. Food and Drug Administration for Investigational Product ACE2016
CI
Acepodia, Inc.(TPEX:6976) added to S&P Global BMI Index
CI
Acepodia Appoints Nobel Laureate Carolyn Bertozzi as Chief Scientific Advisor
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6976 Stock
  4. News Acepodia, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW